Swissotel Nai Lert Park Bangkok
2 Wireless Road, Pathumwan
10330 Bangkok, Thailand
The APHCON (Asia-Pacific Hematology Consortium) is the official host of AUBH2013 and presents the 3rd Annual Updates on Breakthroughs in Hematology with our logistics partner, The Medal Group. Founded in 2007, the Society is a non-profit medical association committed to promoting discourse about and furthering the research of hematology.
After the great success of AUBH2012, we present the 3rd Annual Updates on Breakthroughs in Hematology to be held in Bangkok, Thailand on August 30-31, 2013. The Congress brings together leading authorities in Hematology Oncology to present the latest ground breaking findings on cutting edge research and novel treatments. The discussion forums provide an opportunity to integrate the latest pharmaceutical interventions. The conference targets hematologic malignancies in particular leukemia, lymphoma, and myeloma. The target audience is Southeast and Central Asia, Japan, Australia and the United States.
What is G.A.P?
Global Academic Programs (GAP) facilitates and administers MD Anderson's Sister Institution Network; the largest global network of cancer centers working collaboratively on research and education aimed at lessening the world's cancer burden.
You can stay informed by subscribing to GAP Connect, a weekly newsletter intended to engage and enable global collaborations in cancer research.
Cancer is a leading cause of death in central and Southeast Asia. Hematologic malignancies are an increasing subset of the total cancer incidence rate. In the recent years great improvement in the field of Oncology has taken place with a rapid growth in trained oncologists and cancer centers. However, since the Asian healthcare community is geographically dispersed, it is often characterized by a lack of standardization of treatment and different philosophies of care. Given this fragmentation, there is a need to formalize and integrate conceptual knowledge, disease understanding, therapeutic agent intervention, supportive care, and management of complications.
Since Bangkok is on the leading edge of medicine and especially oncology care, it is an ideal venue for promoting stronger ties between practitioners and researchers from different countries and providing a platform for advancing daily clinical practice. This would in turn improve overall quality of cancer treatment, especially in countries that do not have guaranteed access to the latest breakthroughs.
Our ultimate goal is to help improve the quality of patient care, set standards of clinical competence for practice and encourage the continuing scholarship required for professional excellence over a lifetime of service.
This Congress will be an important step towards implementing a new standard of care and uniformity of knowledge which in turn will bring dividends to cancer patients, physicians and future practitioners.
1. Identify the existing need for the current medical education of the practicing hematologists with an Asian perspective, and build sessions to address the key areas of need.
2. Construct methodology for promoting increased awareness, knowledge and improved practice in the field of malignant hematology in the Asian sector including practice guidelines and the latest therapeutic agents.
3. Encourage and provide opportunity for clinical research in the field of malignant hematology.
AUBH - 2013
This congress will be a productive, interactive and educational experience for the attendees. Top researchers and practitioners from the world over will meet to discuss the current state - and future directions - of Hematologic Malignancies in the Asian sector and explore opportunities for collaborations in order to further the field. The event promises to be a unique medical education forum for the exchange of critical information as well as analyze the challenges faced by the practicing clinicians. It will feature didactic presentations and debates, in which experts will discuss some of the most challenging topics in leukemia, stem cell transplant and mobilization, myelodysplastic syndrome, lymphoma and myeloma, providing a thorough analysis of research breakthroughs and emerging data.
This conference is specifically designed for Hematologists, Oncologists, Transplant Oncologists, Radiation Oncologists, physicians-in-training, and healthcare professionals (nurses, pharmacists, etc) involved in and/or interested in hematologic malignancies and their management. Attendees are expected to be from Southeast and Central Asia, Middle East, Australia, Europe and United States.
ACCOMMODATIONS & CONFERENCE
Attendees will be offered subsidized group rate at the conference venue.
246 Medical Professionals /Healthcare Providers
Estimated 20 international and national experts (culled from a pool of ground-breaking researchers and practitioners) will address the congress.
CONFERENCE REGISTRATION INFORMATION:
The registration fee to attend this conference includes two days of scientific sessions, workshops, lunch sessions, coffee breaks and corporate mini symposiums.
Early Bird Registration: APRIL 15, 2013 – MAY 25, 2013
Regular Registration: MAY 25, 2013- AUGUST 25, 2013
ON Site Registration: AUGUST 29, 2013 - AUGUST 31, 2013
REFUND POLICY: An administrative fee of USD 50 will be deducted from any cancellations made after July 25, 2013. No refunds will be made after AUGUST 15, 2013.